Literature DB >> 32896803

Dynamics of cytokines, immune cell counts and disease severity in patients with community-acquired pneumonia - Unravelling potential causal relationships.

Maciej Rosolowski1, Volker Oberle2, Peter Ahnert3, Petra Creutz4, Martin Witzenrath4, Michael Kiehntopf5, Markus Loeffler3, Norbert Suttorp4, Markus Scholz3.   

Abstract

BACKGROUND: Community acquired pneumonia (CAP) is a severe and often rapidly deteriorating disease. To better understand its dynamics and potential causal relationships, we analyzed time series data of cytokines, blood and clinical parameters in hospitalized CAP patients.
METHODS: Time series data of 10 circulating cytokines, blood counts and clinical parameters were related to baseline characteristics of 403 CAP patients using univariate mixed models. Bivariate mixed models were applied to analyze correlations between the time series. To identify potential causal relationships, we inferred cross-lagged relationships between pairs of parameters using latent curve models with structured residuals.
RESULTS: IL-6 levels decreased faster over time in younger patients (Padj = 0.06). IL-8, VCAM-1, and IL-6 correlated strongly with disease severity as assessed by the sequential organ failure assessment (SOFA) score (r = 0.49, 0.48, 0.46, respectively; all Padj < 0.001). IL-6 and bilirubin correlated with respect to their mean levels and slopes over time (r = 0.36 and r = 0.46, respectively; Padj < 0.001). A number of potential causal relationships were identified, e.g., a negative effect of ICAM-1 on MCP-1, or a positive effect of the level of creatinine on the subsequent VCAM-1 concentration (P < 0.001).
CONCLUSIONS: These results suggest that IL-6 trajectories of CAP patients are associated with age and run parallel to bilirubin levels. The time series analysis also unraveled directed, potentially causal relationships between cytokines, blood parameters and clinical outcomes. This will facilitate the development of mechanistic models of CAP, and with it, improvements in treatment or surveillance strategies for this disease. TRIAL REGISTRATION: clinicaltrials.gov NCT02782013, May 25, 2016, retrospectively registered.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Community-acquired pneumonia; Cytokines; Systemic inflammatory response; Time series

Year:  2020        PMID: 32896803     DOI: 10.1016/j.cyto.2020.155263

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  3 in total

1.  Ulinastatin plus biapenem for severe pneumonia in the elderly and its influence on pulmonary function and inflammatory cytokines.

Authors:  Rui Zhang; Jitao Ma; Pengxiao Zheng; Ruirui Zheng; Xu Meng; Yinjia Wang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Genetic Regulation of Cytokine Response in Patients with Acute Community-Acquired Pneumonia.

Authors:  Andreas Kühnapfel; Katrin Horn; Ulrike Klotz; Michael Kiehntopf; Maciej Rosolowski; Markus Loeffler; Peter Ahnert; Norbert Suttorp; Martin Witzenrath; Markus Scholz
Journal:  Genes (Basel)       Date:  2022-01-06       Impact factor: 4.096

3.  Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.

Authors:  Toni Herta; Aritra Bhattacharyya; Maciej Rosolowski; Claudia Conrad; Corinne Gurtner; Achim D Gruber; Peter Ahnert; Birgitt Gutbier; Doris Frey; Norbert Suttorp; Stefan Hippenstiel; Janine Zahlten
Journal:  Front Immunol       Date:  2021-09-13       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.